However, this combination system is not effective enough to eradicate malignant tumors due to the poor transfection efficiency of the HSV-TK gene, resulting in significantly lower expression levels of the gene product in vitro and in vivo[40]; poor expression of the HSV-TK gene requires that higher doses GCV are used during treatment. Here, TKT is linked to cancer.